CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,728,000 | +11.1% | 541,765 | -0.0% | 0.31% | +31.2% |
| Q4 2021 | $1,555,000 | -27.7% | 541,766 | 0.0% | 0.23% | +30.7% |
| Q3 2021 | $2,151,000 | -33.4% | 541,766 | 0.0% | 0.18% | -31.4% |
| Q2 2021 | $3,229,000 | -50.9% | 541,766 | 0.0% | 0.26% | -47.7% |
| Q1 2021 | $6,577,000 | -17.9% | 541,766 | -1.3% | 0.50% | -11.5% |
| Q4 2020 | $8,007,000 | +15.8% | 548,802 | -8.6% | 0.56% | -5.1% |
| Q3 2020 | $6,914,000 | – | 600,687 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $17,284,000 | 8.25% |
| venBio Partners LLC | 3,673,374 | $42,281,000 | 6.42% |
| Omega Fund Management, LLC | 1,335,050 | $15,366,000 | 4.16% |
| Sofinnova Investments, Inc. | 3,606,707 | $41,513,000 | 3.08% |
| Novo Holdings A/S | 2,170,100 | $24,978,000 | 1.24% |
| CLOUGH CAPITAL PARTNERS L P | 1,313,286 | $14,864,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 600,687 | $6,914,000 | 0.59% |
| CAAS CAPITAL MANAGEMENT LP | 44,966 | $518,000 | 0.01% |
| Zimmer Partners, LP | 25,000 | $288,000 | 0.00% |
| Ensign Peak Advisors, Inc | 119,915 | $1,380,000 | 0.00% |